A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J
Kidney Int 2001;60(6):2406-2411.
Review by
The effect of i.v. iron alone or in combination with low- dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS, Blum M, Agbaria Z, et al.
Clin Nephrol 2001;55(3):212-219.
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U
Haemophilia 2001;7(5):517-522.
Review by M. Aldouri
Appropriateness of red blood cell transfusions in major urban hospitals and effectiveness of an intervention.
Rubin GL, Schofield WN, Dean MG, Shakeshaft AP
Med J Aust 2001;175(7):354-358.
Review by Kretschmer V.
Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
Vichinsky EP, Luban NLC, Wright E, et al.
Transfusion 2001;41(9):1086-1092.
Review by V. Kretschmer.
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659